707 related articles for article (PubMed ID: 25076025)
1. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
3. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
4. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
6. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
7. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
9. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
10. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
11. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
13. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
14. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation.
Zhou Z; Hong EJ; Cohen S; Zhao WN; Ho HY; Schmidt L; Chen WG; Lin Y; Savner E; Griffith EC; Hu L; Steen JA; Weitz CJ; Greenberg ME
Neuron; 2006 Oct; 52(2):255-69. PubMed ID: 17046689
[TBL] [Abstract][Full Text] [Related]
15. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
17. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
[TBL] [Abstract][Full Text] [Related]
18. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
19. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
20. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
